WELBEXUS Trademark
Trademark Overview
On Friday, December 6, 2024, a trademark application was filed for WELBEXUS with the United States Patent and Trademark Office. The USPTO has given the WELBEXUS trademark a serial number of 98889848. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, December 6, 2024. This trademark is owned by Celgene Corporation. The WELBEXUS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and biological preparations for human use.
General Information
| Serial Number | 98889848 |
| Word Mark | WELBEXUS |
| Filing Date | Friday, December 6, 2024 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Friday, December 6, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical and biological preparations for human use. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 6, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Celgene Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08543 |
Trademark Events
| Event Date | Event Description |
| Friday, December 6, 2024 | NEW APPLICATION ENTERED |
